Sign In
Buy LLY
$1,131.42
+6.15 (+0.547%)
At Close: Jun 05, 2026
Roche Setback Is Big for Eli Lilly, Novo Nordisk as Obesity Drug Battle Ramps Up
08:01am, Thursday, 12'th Sep 2024
The company's stock was falling after a report detailing side effects from its once-daily weight-loss pill.
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production
05:36am, Thursday, 12'th Sep 2024
Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
05:30am, Thursday, 12'th Sep 2024
Eli Lilly will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer's drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland. The pharm
Lilly expands manufacturing footprint in Ireland with $1.8 billion investment
05:30am, Thursday, 12'th Sep 2024
Company ups manufacturing investment in Limerick by $1 billion; unveils new $800 million Kinsale facility New investment will enhance global medicine production, benefiting millions of patients world
2 Weight Loss Drug Stocks Worth Stashing Away for Years
02:40pm, Wednesday, 11'th Sep 2024
As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to the chin.
Health Rounds: Once-weekly insulin from Eli Lilly appears effective as daily injections
01:09pm, Wednesday, 11'th Sep 2024
Eli Lilly's experimental insulin that is injected just once a week is as effective as daily insulin injections for maintaining blood sugar levels in patients with type 1 or type 2 diabetes, researcher
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)
08:20am, Wednesday, 11'th Sep 2024
Eli Lilly has been an innovative force in medicine for a long time. The company is making waves for its progress in weight loss and Alzheimer's, but there is another big reason Lilly should be on your
Prediction: These 2 Companies Will Split Their Stocks by 2027
06:45am, Wednesday, 11'th Sep 2024
These two drugmakers have been delivering significantly above-average returns for years. Both still have excellent prospects and could decide to split their stocks as their share prices get higher.
Detailed results were published in The Lancet and simultaneously presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024 INDIANAPOLIS , Sept. 10, 2024 /PRNewswire/ -
In QWINT-2, efsitora helped adults naïve to insulin therapy currently using and not using GLP-1 receptor agonists achieve an A1C below 7% Detailed results were published in The New England Journal
Best Momentum Stocks to Buy for September 10th
11:16am, Tuesday, 10'th Sep 2024
LLY, MCO, and BCH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 10, 2024.
New Strong Buy Stocks for September 10th
09:05am, Tuesday, 10'th Sep 2024
CLCO, BCH, ZUO, LLY and LYTS have been added to the Zacks Rank #1 (Strong Buy) List on September 10, 2024.
Lilly appoints insider as finance chief amid rising investments to boost capacity
03:25pm, Monday, 09'th Sep 2024
U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi stepped down to join G
Calls of the Day: Eli Lilly and Netflix
01:08pm, Monday, 09'th Sep 2024
The Investment Committee debates how to trade these names: Netflix and Eli Lilly.
While reported use of Sanofi/Regeneron's Dupixent has declined with the adoption of LEO's Adbry, Pfizer's Cibinqo, and AbbVie's Rinvoq, the overall population receiving advanced treatments is on the r
